In Re Synergy Pharmaceuticals Inc. Securities Litigation

CourtDistrict Court, E.D. New York
DecidedSeptember 28, 2020
Docket1:18-cv-00873
StatusUnknown

This text of In Re Synergy Pharmaceuticals Inc. Securities Litigation (In Re Synergy Pharmaceuticals Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Synergy Pharmaceuticals Inc. Securities Litigation, (E.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK --------------------------------------------------------------- X : IN RE SYNERGY PHARMACEUTICALS INC. SECURITIES LITIGATION, : MEMORANDUM DECISION & ORDER : 18-CV-873 (AMD) (VMS) : 19-CV-825 (AMD) (VMS) : : --------------------------------------------------------------- X: : GARY MCMULLEN, Individually and on Behalf : : of All Others Similarly Situated, : : Plaintiff, :

- against - : : TROY HAMILTON, GARY S. JACOB, and GARY G. GEMIGNANI, Defendants. : : --------------------------------------------------------------- X

: ANN M. DONNELLY, United States District Judge:

: On November 20, 2019, Magistrate Judge Vera M. Scanlon consolidated the McMullen

and Weber actions into In re Synergy Pharmaceuticals Inc. Securities Litigation, No. 1:18-CV- 00873-AMD-VMS (“In re Synergy”). (See S-ECF No. 90.) 1 Before the Court is McMullen’s motion to set aside or modify Judge Scanlon’s order. (S-ECF No. 94.) The lead plaintiffs and the defendants oppose. For the reasons that follow, McMullen’s request is denied.

1 For ease of reference, this decision adopts the citations and abbreviations used in Judge Scanlon’s November 20, 2019 order, including: (1) ECF documents filed in the McMullen case: “M-ECF”; (2) documents filed in the Weber case: “W-ECF”; and (iii) documents filed in In re Synergy: “S-ECF.” DISCUSSION The background of this litigation is detailed in Judge Scanlon’s comprehensive order, and will not be repeated here. On November 20, 2019, after extensive briefing from all parties, and in a thorough and well-reasoned decision, Judge Scanlon consolidated the McMullen and Weber actions with In re Synergy, finding that “the facts and allegations asserted in the McMullen and

Weber actions clearly arise ‘out of the subject matter of the Consolidated Action,’ . . . and involve common questions of law and fact[.]” (S-ECF No. 90 at 7 (quoting S-ECF No. 51 at 4).) McMullen challenges the decision to consolidate McMullen and Synergy, arguing—as he did before Judge Scanlon—that the two actions do not share common questions of fact and do not involve the same class period. McMullen also claims that Judge Scanlon violated the PSLRA by limiting McMullen’s ability to pursue class claims if the lead plaintiffs do not pursue those claims in their second amended complaint. Finally, McMullen argues that the lead plaintiffs are conflicted and will not adequately pursue McMullen’s claims.2 I. Legal Standard

Rule 72(a) of the Federal Rules of Civil Procedure, which governs a district judge’s review of a magistrate judge’s non-dispositive pretrial rulings, provides that “[t]he district judge . . . must consider timely objections and modify or set aside any part of the order that is clearly erroneous or is contrary to law.” Fed. R. Civ. P. 72(a); see also 28 U.S.C. § 636(b)(1)(A) (“A judge of the court may reconsider any pretrial matter . . . where it has been shown that the magistrate judge’s order is clearly erroneous or contrary to law.”). An order is “clearly erroneous if, based on all the evidence, a reviewing court ‘is left with the definite and firm conviction that a mistake has been committed,’” Storms v. United States, No. 13-CV-0811, 2014

2 Weber did not oppose or otherwise object to Judge Scanlon’s decision. WL 3547016, at *4 (E.D.N.Y. July 16, 2014) (quoting United States v. Murphy, 703 F.3d 182, 188 (2d Cir. 2012)), and “is ‘contrary to law’ when it fails to apply or misapplies relevant statutes, case law, or rules of procedure,” Weiner v. McKeefery, No. 11-CV-2254, 2014 WL 2048381, at *3 (E.D.N.Y. May 19, 2014) (citation and quotation omitted). “This standard is highly deferential, imposes a heavy burden on the objecting party, and only permits reversal

where the magistrate judge abused [her] discretion.” Ahmed v. T.J. Maxx Corp., 103 F. Supp. 3d 343, 350 (E.D.N.Y. 2015) (quotations and citations omitted). McMullen argues that Judge Scanlon’s order is subject to de novo review, rather than a review for clear error. Since Judge Scanlon’s decision was obviously correct under either standard, the difference is largely academic, but the correct standard of review is for clear error. Under Rule 72(a), an order granting a motion to consolidate is a nondispositive order, and is not subject to de novo review. See, e.g., Pompano Beach Police & Firefighters’ Ret. Sys. v. Comtech Telecomms. Corp., No. 09-CV-3007, 2010 WL 3909331, at *1-2 (E.D.N.Y. Sept. 29, 2010) (applying clearly erroneous standard of review in considering magistrate judge’s order on motion

to consolidate); Wilson v. Gen. Mills, Inc., No. 08-CV-00597(S)(M), 2009 WL 10681447, at *1 n.3 (W.D.N.Y. July 6, 2009) (“A motion to consolidate implicates nondispositive relief.”) (quotation omitted); Algonquin Power Corp. v. Trafalgar Power Inc., No. 00-CV-1246, 2000 WL 33963085, at *5 (N.D.N.Y. Nov. 8, 2000) (consolidation order pursuant to Rule 42(a) “implicates nondispositive relief”). II. McMullen’s First Objection Rule 42(a) permits consolidation of actions that involve “a common question of law or fact.” Fed. R. Civ. P. 42(a). As Judge Scanlon observed, Rule 42(a) grants the Court “‘broad discretion to determine whether to consolidate actions,’” and to consider “whether judicial economy favors consolidation.” (S-ECF No. 90 at 6 (quoting Kaplan v. Gelfond, 240 F.R.D. 88, 91 (S.D.N.Y. 2007)). The Court’s standing consolidation order also requires “[e]ach new case that arises out of the subject matter of the Consolidated Action . . . shall, upon the Court’s approval, be consolidated into the Consolidated Action.” (S-ECF No. 51 ¶¶ 1, 4, 7-9.) McMullen argues that I should set aside Judge Scanlon’s order consolidating McMullen

and In re Synergy because the actions “do not involve any common questions of fact” and allege different class periods. (S-ECF No. 94 at 4) (alteration omitted). Consolidation of separate securities class actions is appropriate where there are “[d]ifferences in causes of action, defendants, or the class period” as long as “the cases present sufficiently common questions of fact and law, and the differences do not outweigh the interests of judicial economy served by consolidation.” Kaplan, 240 F.R.D. at 91 (citation omitted). All three actions allege violations of the same laws, focus on the same or similar misstatements or omissions, and propose overlapping class periods. McMullen and Synergy are driven by a shared set of common questions of law and fact: what the defendants knew about the company’s performance,

Synergy’s ability to meet the conditions of the loan it secured, and the degree to which the defendants knew any adverse information that, if disclosed, might have affected the stock price. (See, e.g., McMullen Compl. ¶¶ 19-21, 31, CAC ¶¶ 77-78, 83, 89, 94 (relying on the same loan announcement and statements made by the defendants); McMullen Compl. ¶¶ 66-71; CAC ¶¶ 170-186 (asserting the same causes of action); McMullen Compl. ¶ 64; CAC ¶ 158 (asserting overlapping “common questions of law and fact” regarding each action’s respective putative class members); McMullen Compl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Murphy
703 F.3d 182 (Second Circuit, 2012)
Ahmed v. T.J. Maxx Corp.
103 F. Supp. 3d 343 (E.D. New York, 2015)
Hevesi v. Citigroup Inc.
366 F.3d 70 (Second Circuit, 2004)
Kaplan v. Gelfond
240 F.R.D. 88 (S.D. New York, 2007)
Strougo v. Brantley Capital Corp.
243 F.R.D. 100 (S.D. New York, 2007)
Sklar v. Bank of America Corp.
258 F.R.D. 260 (S.D. New York, 2009)
Foley v. Transocean Ltd.
272 F.R.D. 126 (S.D. New York, 2011)
In re Cendant Corp. Litigation
182 F.R.D. 476 (D. New Jersey, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
In Re Synergy Pharmaceuticals Inc. Securities Litigation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-synergy-pharmaceuticals-inc-securities-litigation-nyed-2020.